
    
      This study is to measure the "real-world" acute procedural outcomes (procedural efficiency,
      acute safety, and effectiveness at one year) associated with use of the NAVISTAR® THERMOCOOL®
      SF Catheter in a clinical setting in subjects with drug refractory, recurrent symptomatic
      paroxysmal atrial fibrillation.
    
  